ArticleJournal of clinical pharmacology2026
Response to Comment on "Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma".
Hiroyuki Inoue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.